AU2002365198A1 - Novel anti-infectives - Google Patents
Novel anti-infectivesInfo
- Publication number
- AU2002365198A1 AU2002365198A1 AU2002365198A AU2002365198A AU2002365198A1 AU 2002365198 A1 AU2002365198 A1 AU 2002365198A1 AU 2002365198 A AU2002365198 A AU 2002365198A AU 2002365198 A AU2002365198 A AU 2002365198A AU 2002365198 A1 AU2002365198 A1 AU 2002365198A1
- Authority
- AU
- Australia
- Prior art keywords
- infectives
- novel anti
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33854201P | 2001-10-30 | 2001-10-30 | |
| US60/338,542 | 2001-10-30 | ||
| PCT/US2002/034591 WO2003059356A2 (en) | 2001-10-30 | 2002-10-28 | Novel anti-infectives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002365198A1 true AU2002365198A1 (en) | 2003-07-30 |
Family
ID=23325196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002365198A Abandoned AU2002365198A1 (en) | 2001-10-30 | 2002-10-28 | Novel anti-infectives |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002365198A1 (en) |
| WO (1) | WO2003059356A2 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL376823A1 (en) * | 2002-11-01 | 2006-01-09 | Abbott Laboratories | Anti-infective agents |
| JP4738172B2 (en) * | 2002-11-01 | 2011-08-03 | アボット・ラボラトリーズ | Antiinfectives |
| US7902203B2 (en) | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
| TWI368507B (en) | 2004-02-20 | 2012-07-21 | Boehringer Ingelheim Int | Viral polymerase inhibitors |
| ATE437875T1 (en) * | 2004-08-23 | 2009-08-15 | Hoffmann La Roche | HETEROCYCLIC ANTIVIRAL COMPOUNDS |
| AR054214A1 (en) | 2004-12-17 | 2007-06-13 | Anadys Pharmaceuticals Inc | COMPOUNDS DERIVED FROM 1, 1 - DIOXOTIADIAZINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF INFECTION BY THE VIRUS OF HEPATITIS C. |
| MX2007007482A (en) | 2004-12-21 | 2007-07-20 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof as 5-ht antagonists. |
| CN101189230A (en) | 2005-05-04 | 2008-05-28 | 弗·哈夫曼-拉罗切有限公司 | Antiviral heterocyclic compounds |
| MX2008015843A (en) | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof. |
| CA2654822A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| CA2655524A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffman-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
| KR101384266B1 (en) | 2006-06-22 | 2014-04-24 | 애나디스 파마슈티칼스, 인코포레이티드 | Pyrro[1,2-ｂ]pyridazinone compounds |
| WO2008011337A1 (en) * | 2006-07-19 | 2008-01-24 | Abbott Laboratories | Hcv inhibitors |
| HRP20110193T1 (en) | 2006-10-10 | 2011-05-31 | Medivir Ab | INHIBITOR HCV NUKLEOZIDA |
| CL2007003587A1 (en) | 2006-12-12 | 2008-07-04 | Anadys Pharmaceuticals Inc | COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE TO TREAT OR PREVENT INFECTION OF HEPATITIS C. |
| US20080214529A1 (en) * | 2006-12-12 | 2008-09-04 | Frank Ruebsam | SATURATED FUSED [1,2-b]PYRIDAZINONE COMPOUNDS |
| UA100120C2 (en) | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
| US7834009B2 (en) | 2007-08-27 | 2010-11-16 | Anadys Pharmaceuticals, Inc. | 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds |
| GB0800855D0 (en) * | 2008-01-17 | 2008-02-27 | Syngenta Ltd | Herbicidal compounds |
| TWI438206B (en) | 2008-06-10 | 2014-05-21 | Anadys Pharmaceuticals Inc | [1,2,4]thiadiazine 1,1-dioxide compounds |
| TW201026675A (en) | 2008-10-09 | 2010-07-16 | Anadys Pharmaceuticals Inc | 5,6-dihydro-1H-pyridin-2-one compounds |
| US20110229438A1 (en) | 2008-10-09 | 2011-09-22 | Anadys Pharmaceuticals, Inc. | Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
| CN102203090A (en) * | 2008-10-29 | 2011-09-28 | 巴斯夫欧洲公司 | Substituted pyridines having a herbicidal effect |
| EP2403844A1 (en) | 2009-03-06 | 2012-01-11 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
| EP2421831A1 (en) | 2009-04-25 | 2012-02-29 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
| BRPI1010900A2 (en) * | 2009-05-20 | 2016-03-15 | Hoffmann La Roche | heterocyclic antiviral compounds |
| SG176976A1 (en) | 2009-06-24 | 2012-02-28 | Hoffmann La Roche | Heterocyclic antiviral compound |
| BR112012005616A2 (en) | 2009-09-21 | 2016-06-21 | Hoffmann La Roche | heterocyclic antiviral compounds |
| BR112012009796A2 (en) | 2009-10-28 | 2020-08-18 | Anadys Pharmaceuticals, Inc. | compound, methods for treating or preventing hepatitis c virus infections in a mammal in need of these uses of compound and pharmaceutical composition. |
| BR112012012085A2 (en) | 2009-11-21 | 2016-05-17 | Hoffmann La Roche | heterocyclic antiviral compounds |
| US20120321590A1 (en) | 2011-04-06 | 2012-12-20 | Anadys Pharmaceuticals, Inc. | Bridged polycyclic compounds |
| WO2021030278A1 (en) * | 2019-08-12 | 2021-02-18 | Aligos Therapeutics, Inc. | Bicyclic compounds |
-
2002
- 2002-10-28 AU AU2002365198A patent/AU2002365198A1/en not_active Abandoned
- 2002-10-28 WO PCT/US2002/034591 patent/WO2003059356A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003059356A3 (en) | 2004-01-22 |
| WO2003059356A2 (en) | 2003-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002365198A1 (en) | Novel anti-infectives | |
| AU2001261377A1 (en) | Novel anti-infectives | |
| IL158992A0 (en) | Novel anti-infectives | |
| AU2002313565A1 (en) | Putter-heads | |
| AU2003248566A1 (en) | Novel anti-infectives | |
| AU2002359320A1 (en) | Novel anit-infectives | |
| AU2001259511A1 (en) | Novel anti-infectives | |
| AU2003297235A1 (en) | Anti-infectives | |
| AU2003300957A1 (en) | Anti-infectives | |
| AU2003300956A1 (en) | Anti-infectives | |
| AU2002359464A1 (en) | Angiopioetin related factors | |
| AU2002330025A1 (en) | Atlastin | |
| AU2002313943A1 (en) | Electromobile | |
| AU2002226571A1 (en) | Biligands | |
| AU2001100406A4 (en) | DriverSMS | |
| AU2002313073A1 (en) | Phytocystatin | |
| AU2002257925A1 (en) | Numberplates | |
| AU2002254979A1 (en) | Novel sulfonylamino-pyrimidines | |
| AU2002253663A1 (en) | Novel maxizyme | |
| AU2002100746A4 (en) | Adrail | |
| AU2001100532A4 (en) | FonePark | |
| AU2001100214A4 (en) | Dolly-trolley | |
| AU2001100338A4 (en) | Sunglove | |
| AU2001100522A4 (en) | e-Trans | |
| AU2002355888A1 (en) | Novel combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |